Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer.

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

August 3, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

May 1, 2020

Conditions
Pancreatic Cancer
Interventions
DEVICE

Back-loaded Needle (Device)

"Fiducial marker placement via a traditional 22G back-loaded needle will be performed with multiple endpoints recorded:~* total length of procedure~* how many markers are successfully deployed~* technical success~Fiducial marker location will be confirmed via fluoroscopy at time of placement and on 4D treatment planning CT ordered by the radiation oncologist for simulation."

DEVICE

Preloaded Needle (Device)

"Fiducial marker placement via a novel 22G preloaded needle will be performed with multiple endpoints recorded:~* total length of procedure~* how many markers are successfully deployed~* technical success~Fiducial marker location will be confirmed via fluoroscopy at time of placement and on 4D treatment planning CT ordered by the radiation oncologist for simulation."

Trial Locations (2)

33612

Moffitt Cancer Center, Tampa

80045

University of Colorado Hospital, Aurora

All Listed Sponsors
collaborator

Cook Group Incorporated

INDUSTRY

lead

University of Colorado, Denver

OTHER

NCT02332863 - Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer. | Biotech Hunter | Biotech Hunter